EX-23.2 4 a95403a1exv23w2.txt EXHIBIT 23.2 EXHIBIT 23.2 INDEPENDENT AUDITORS' CONSENT We consent to the incorporation by reference in this Amendment No. 1 to Registration Statement No. 333-111680 of AVANIR Pharmaceuticals on Form S-3 of our report dated December 19, 2003, appearing in the Annual Report on Form 10-K of AVANIR Pharmaceuticals for the year ended September 30, 2003 and to the reference to us under the heading "Experts" in the Prospectus, which is part of this Registration Statement. /s/ Deloitte & Touche LLP San Diego, California January 26, 2004